# To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant Recipients

> **NCT03423225** · PHASE4 · COMPLETED · sponsor: **Kim, Seoung-Hoon** · enrollment: 31 (actual)

## Conditions studied

- Liver Transplantation

## Interventions

- **DRUG:** ADVAGRAF®

## Key facts

- **NCT ID:** NCT03423225
- **Lead sponsor:** Kim, Seoung-Hoon
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-22
- **Primary completion:** 2017-07-18
- **Final completion:** 2017-12-14
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2018-02-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03423225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03423225, "To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant Recipients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03423225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*